Importance People who have been infected with or vaccinated against SARS-CoV-2 have
reduced risk of subsequent infection, but the proportion of people in the US with SARS-CoV-2 …

The development of neutralizing antibodies (NAbs) against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) following infection or vaccination is likely to be critical for …

Influenza viruses typically cause the most severe disease in children and elderly individuals.
However, H1N1 viruses disproportionately affected middle-aged adults during the 2013–…

OBJECTIVE: To examine the association of prenatal exposure to bisphenol A and select
common phthalates with infant neurobehavior measured at 5weeks. METHODS: We compared …

Since the beginning of the COVID‐19 pandemic, the use of convalescent plasma as a
possible treatment has been explored. Here we describe our experience as the first US …

Background The development of neutralizing antibodies (NAbs) against SARS-CoV-2, following
infection or vaccination, is likely to be critical for the development of sufficient population …

Background The Recipient Epidemiology and Donor Evaluation Study-IV-Pediatric (REDS-IV-P)
Epidemiology, Surveillance and Preparedness of the Novel SARS-CoV-2 Epidemic (…

Background Convalescent plasma (CP) for treatment of severe acute respiratory syndrome
coronavirus 2 (SARS‐CoV‐2) has shown preliminary signs of effectiveness in moderate to …

Background SARS‐CoV‐2 RNA prevalence in blood donors from large geographic areas of
high community transmission is limited. We tested residual donor plasma minipools (MPs) to …

The COVID‐19 pandemic severely tested the resilience of the US blood supply with wild
fluctuations in blood donation and utilisation rates as community donation opportunities ebbed …